Internal audit rates Texas State Board of Pharmacy compliance 'strong'; two low-risk findings remain open

Board staff reported near-completion of the Texas State Board of Pharmacy's 2025 internal audit plan and presented findings that included a strong overall rating for internal agency compliance and a closed high-risk enforcement finding.

An internal audit presenter told the Board the internal agency compliance audit, completed shortly after the February 14 meeting, received "strong" ratings for both objectives A and B. The presenter said two findings from that report were low risk and concerned segregation of duties and the need for greater cross-training because a large amount of reporting knowledge is concentrated in a few individuals.

The enforcement follow-up report, issued April 25, showed that a previously open high-risk finding from the fiscal year 2023 enforcement report — lack of a secondary review of complaints and investigations by supervisory personnel — has been remediated, the presenter said. The internal audit staff verified the remediation through testing and issued a strong rating for the follow-up.

The presenter summarized the status table showing only two open findings remain; both are low risk and are not IT-related (the presenter said IT-related items are not disclosed publicly for security reasons). The presenter also said the annual audit report guidance typically issues in August and that the agency's annual report to the state auditor's office, the Legislative Budget Board and the governor is due Nov. 1; a draft is expected by the next board meeting.

The transcript attributes the report and these details to the internal audit presenter; no formal board action or vote was recorded on the internal audit items in the excerpt provided.